The heme protein indoleamine 2,3-dioxygenase (IDO) initiates oxidative metabolism of tryptophan along the kynurenine pathway, and this requires reductive activation of Fe . plays a major role in the activation of IDO in human cells.Human indoleamine 2,3-dioxygenase (IDO) 3 is a cellular enzyme that catalyzes the initial step of the oxidative metabolism of L-tryptophan (L-Trp) along the kynurenine pathway (1, 2). IDO cleaves the pyrrole ring of L-Trp to N-formyl-kynurenine by incorporating molecular oxygen. Although L-Trp is preferred, the enzyme can use other indoleamines such as tryptamine and serotonin as substrates. IDO is expressed constitutively in a limited number of human tissues (3) and also in rabbit enterocytes (4), but in most tissues and cells, expression of the enzyme requires induction, with the pro-inflammatory cytokine interferon-␥ (IFN␥) playing a major role (2). The true physiological function of IDO is becoming clearer, with its induction and the formation of kynurenine pathway metabolites implicated in various physiological and pathological processes, such as in the defense against microbes and tumors, immune regulation, neuropathology, and antioxidant activity (2).IDO is a monomeric protein of 42-kDa molecular mass and contains protoporphyrin IX as its sole prosthetic group (4).